RPS6KB1 and breast cancer: To further investigate the efficacy of the combination therapy, we identified 3 organoids with amplified S6K1 gene, KOBR-011, KOBR-029, and KOBR-716, from 32 organoids derived from patients with breast cancer (3/32, 9.4%, Fig. 1C).